HK Stock Market Move | Concept stocks of brain-computer interface opened collectively. China has completed three cases of invasive brain-computer interface clinical trials.
Brain-machine concept stocks collectively opened higher. As of the time of writing, Brainhole Aurora (06681) rose 10.35% to HKD 6.29; Nanjing Panda Electronics Co. (00553) rose 1.63% to HKD 4.36.
Concept stocks related to brain-machine interfaces collectively opened higher. As of the time of publication, BrainCo (06681) rose by 10.35%, closing at 6.29 Hong Kong dollars; NANJING PANDA (00553) rose by 1.63%, closing at 4.36 Hong Kong dollars.
On the news front, according to Securities Times, the research team of Zhao Zhengtuo and Li Xue from the Chinese Academy of Sciences Center for Excellence in Brain Science and Intelligent Technology has already collaborated with relevant hospitals and enterprises this year to complete three cases of invasive brain-machine interface clinical trials, achieving breakthroughs in the application of real-life scenarios. In the second clinical trial, the research team used a high-throughput wireless invasive brain-machine interface system to enable a high-level paralyzed patient to control an intelligent wheelchair and a robotic dog stably through brain signals, achieving independent movement and item access in real-life scenarios.
China Securities Co., Ltd. believes that the technological progress in the middle and upper reaches of the brain-machine interface industry chain has continuously brought breakthroughs to the downstream application end. In recent years, milestone achievements have emerged in medical research in fields such as motor recovery, language communication, and hearing reconstruction both domestically and internationally. At the national and regional levels, various favorable policies have been introduced to accelerate the industry's development. Recently, the National Medical Insurance Administration issued a document separately listing the prices for new brain-machine interface technologies, paving the way for their entry into clinical applications. With technological innovation and policy dividends, domestic brain-machine interface companies are expected to gradually achieve commercial applications.
Related Articles

Nanhua Futures (603093.SH): The final price for the H share issuance has been set at 12 Hong Kong dollars per share.

Bank of America Securities: Upgrades Guotai Haitong (02611) rating to "buy" with a target price of HK$20.2. Listed as the top stock pick for next year.

Shareholder Li Chunhua of Leedarson IoT Technology Inc. (605365.SH) decreased his holdings by 1.56% of the company's shares between December 10th and December 17th.
Nanhua Futures (603093.SH): The final price for the H share issuance has been set at 12 Hong Kong dollars per share.

Bank of America Securities: Upgrades Guotai Haitong (02611) rating to "buy" with a target price of HK$20.2. Listed as the top stock pick for next year.

Shareholder Li Chunhua of Leedarson IoT Technology Inc. (605365.SH) decreased his holdings by 1.56% of the company's shares between December 10th and December 17th.

RECOMMEND

Super Central Bank Week Arrives! Japan Leads With A Rate Hike As Developed Economies End The Rate‑Cut Cycle, Will The Fed Cut Alone Next Year?
16/12/2025

What Guidance Does The Economic Work Conference Offer For Cross‑Year Market Direction?
16/12/2025

Trade Surplus Tops One Trillion USD: New Challenges For China’s Foreign Trade | Instant Commentary
16/12/2025


